🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kelly Chin

Southwestern Medical Center

ORCID: 0000-0002-1214-6723

Also affiliated with The University of Texas Southwestern Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.3Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE

The Journal of Heart and Lung Transplantation(2021)10.1016/j.healun.2021.01.006
Top 16%
1.3DataRank
Top 16%23 citations

Anna R. Hemnes, Murali M. Chakinala, Kristin B. Highland, Kelly Chin, Vallerie V. McLaughlin +4 more

Papers

Driven by 5 papers — median percentile 82. Top paper: “Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry”.

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry

CHEST Journal(2021)10.1016/j.chest.2021.05.052
N/A
2.4DataRank · unranked
74 citations

C. Gregory Elliott, Kelly Chin, Raymond L. Benza, Richard N. Channick, R. Duane Davis +12 more

Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE

The Journal of Heart and Lung Transplantation(2021)10.1016/j.healun.2021.01.006
Top 16%
1.3DataRank
Top 16%23 citations

Anna R. Hemnes, Murali M. Chakinala, Kristin B. Highland, Kelly Chin, Vallerie V. McLaughlin +4 more

Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)

The Journal of Heart and Lung Transplantation(2023)10.1016/j.healun.2023.09.016
Top 20%
0.995DataRank
Top 20%27 citations

Harrison W. Farber, Kristin B. Highland, Anna R. Hemnes, Murali M. Chakinala, Kelly Chin +6 more

Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot study

Pulmonary Circulation(2020)10.1177/2045894020971954
N/A
0DataRank · unranked
11 citations

Sonja Bartolome, Oluwatosin Igenoza, Kelly Chin, Adetoun Sodimu

Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension

CHEST Journal(2021)10.1016/j.chest.2021.01.066
N/A
0DataRank · unranked
38 citations

Olivier Sitbon, Richard N. Channick, Kelly Chin, Rafael Sauter, Nazzareno Galiè +9 more